Jason T. Shackelford

Jason T. Shackelford appears in our data through filings on Oncternal Therapeutics, Inc. shares, published by SEC (Form 4). Between 1 June 2014 and 20 June 2018, the trades on record add up to 7 filings.

On the open market, the record shows 1 purchase worth €6,866 and 3 sales worth €181k. Sales outweigh purchases by €174k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. Since January 2018: no purchases and 3 sales on the market.

Most recently, on 22 June 2018, the filings show an open-market sale worth €152k in Oncternal Therapeutics, Inc. The most recent open-market purchase was published on 7 August 2014, 4,477 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.